WEKO3
-
RootNode
アイテム
Critical roles of cold shock domain protein A as an endogenous angiogenesis inhibitor in skeletal muscle
https://asahikawa-med.repo.nii.ac.jp/records/4552
https://asahikawa-med.repo.nii.ac.jp/records/45524a0a9ffa-eccf-4eee-b699-9b8a832c7cf3
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article_02(1) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2013-07-24 | |||||||||||||||||||||||||
タイトル | ||||||||||||||||||||||||||
タイトル | Critical roles of cold shock domain protein A as an endogenous angiogenesis inhibitor in skeletal muscle | |||||||||||||||||||||||||
言語 | en | |||||||||||||||||||||||||
言語 | ||||||||||||||||||||||||||
言語 | eng | |||||||||||||||||||||||||
資源タイプ | ||||||||||||||||||||||||||
資源タイプ | journal article | |||||||||||||||||||||||||
著者 |
齊藤, 幸裕
× 齊藤, 幸裕
× Nakagami, Hironori
× Azuma, Nobuyoshi
× Hirata, Satoshi
× Sanada, Fumihiro
× Taniyama, Yoshiaki
× Morishita, Ryuichi
× Kaneda, Yasufumi
× Sasajima, Tadahiro
|
|||||||||||||||||||||||||
書誌情報 |
Antioxidants & redox signaling 巻 15, 号 8, p. 2109-2120, 発行日 2011-10-01 |
|||||||||||||||||||||||||
ISSN | ||||||||||||||||||||||||||
収録物識別子タイプ | PISSN | |||||||||||||||||||||||||
収録物識別子 | 1523-0864 | |||||||||||||||||||||||||
DOI | ||||||||||||||||||||||||||
関連タイプ | isIdenticalTo | |||||||||||||||||||||||||
識別子タイプ | DOI | |||||||||||||||||||||||||
関連識別子 | 10.1089/ars.2010.3714 | |||||||||||||||||||||||||
PubMed番号 | ||||||||||||||||||||||||||
識別子タイプ | PMID | |||||||||||||||||||||||||
関連識別子 | 21473684 | |||||||||||||||||||||||||
抄録 | ||||||||||||||||||||||||||
内容記述タイプ | Abstract | |||||||||||||||||||||||||
内容記述 | Angiogenesis is regulated by the local balance between angiogenic stimulators and inhibitors and is maintained by muscle-derived angiogenic factors in ischemic tissues. AIMS: Our objectives were to investigate the effect of cold shock domain protein A (CSDA) as an endogenous angiogenesis inhibitor and to develop a novel strategy of therapeutic angiogenesis by blocking CSDA expression. RESULTS: In human skeletal muscle cells, CSDA was upregulated during hypoxia when cells were damaged and apoptosis was induced. CSDA expression could repress the activity of hypoxia inducible factor-1α and nuclear factor κB, because CSDA can competitively bind the hypoxia response element and the nuclear factor κB-binding element. As a result, vascular endothelial growth factor-A, interleukin-6, and interleukin-8 secretions from skeletal muscle cells were decreased. Further, CSDA depletion increased the secretion level of these angiogenic factors. In a hindlimb ischemia model, transfer of short-hairpin RNA targeting CSDA ameliorated ischemia without direct transfer of angiogenic factors. In this ischemic tissue, vascular endothelial growth factor-A, interleukin-6, and CXCL2 protein levels were increased. INNOVATION AND CONCLUSION: CSDA appears to play a critical role as an endogenous angiogenesis inhibitor in skeletal muscle, and RNA interference targeting of CSDA is a promising gene therapy strategy for treating peripheral arterial disease. | |||||||||||||||||||||||||
言語 | en | |||||||||||||||||||||||||
注記 | ||||||||||||||||||||||||||
内容記述タイプ | Other | |||||||||||||||||||||||||
注記 | Publisher | |||||||||||||||||||||||||
資源タイプ | ||||||||||||||||||||||||||
内容記述タイプ | Other | |||||||||||||||||||||||||
資源タイプ | text | |||||||||||||||||||||||||
著者版フラグ | ||||||||||||||||||||||||||
出版タイプ | VoR | |||||||||||||||||||||||||
フォーマット | ||||||||||||||||||||||||||
内容記述タイプ | Other | |||||||||||||||||||||||||
内容記述 | application/pdf | |||||||||||||||||||||||||
ID(XooNIps) | ||||||||||||||||||||||||||
21473684 | ||||||||||||||||||||||||||
閲覧数(XooNIps) | ||||||||||||||||||||||||||
ダウンロード数(XooNIps) | ||||||||||||||||||||||||||
563 |
Share
Cite as
齊藤, 幸裕, Nakagami, Hironori, Azuma, Nobuyoshi, Hirata, Satoshi, Sanada, Fumihiro, Taniyama, Yoshiaki, Morishita, Ryuichi, Kaneda, Yasufumi, Sasajima, Tadahiro, n.d., Critical roles of cold shock domain protein A as an endogenous angiogenesis inhibitor in skeletal muscle: 2109–2120 p.
Loading...